Your Daily News Roundup

We’re all in this together! 

Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place. 

Researchers, advocates, clinicians, and organizations around the country and across the web have been hard at work, creating resources for people living with T1D to better cope with the ongoing COVID-19 coronavirus pandemic.

We’re going to take the opportunity to share out some of those resources each week that may help people get through this challenging time with the help of partners and experts.

Our CEO David Walton sat down this week with Scott Benner, host of the Juicebox Podcast. They discussed strategies for dealing with the disease, opportunities to improve outcomes through education, use of technology with diabetes, and more.

Listen Now!

Take a look! 

Here are some of the stories to keep an eye on this week.

  • Dexcom. A technological leader in continuous glucose monitoring (CGM), has announced a new patient assistance program to aid current U.S. customers who have lost insurance due to the COVID-19 pandemic.
  • Insulet. The global leader in tubeless insulin pump technology expands its U.S. Financial Assistance Program for current users impacted by COVID-19.
  • Novo Nordisk, Inc. People with diabetes using Novo Nordisk insulin, who have lost health insurance coverage because of a change in job status due to the COVID-19 pandemic, may now be eligible for enrollment in their Assistance Program and receive free 90-day insulin supply. 

Here are a few of the most exciting and important resources that we’ve seen about this topic in the last few weeks — we’ll be updating the list regularly as time goes on:

We here at T1D Exchange are doing our part, launching the first targeted surveillance study of people with T1D who are positively or probably diagnosed with the COVID-19 coronavirus. 

Beyond Type 1 has compiled a list of specific actions you can take in your daily life to have a real positive impact on the current situation. 

Glooko, a remote-monitoring diabetes company, is now offering its remote-care solution to medical clinics & people with diabetes, at no charge. 

JDRF hosted an extremely helpful webinar with Dr. Mary Pat Gallagher, a pediatric endocrinologist with NYU Langone Health, Hassenfeld Children’s Hospital, about the challenges of coronavirus and T1D.

Lilly announced a $35 co-pay option for most Lilly insulins, including the extremely popular Humalog, through its Lilly Insulin Value Program. People with T1D who use Lilly insulin can contact the  Lilly Diabetes Solution Center at 833-808-1234 to figure out their eligibility.

Tidepool, a non-profit organization that provides free software and cloud solutions to people with T1D, is providing telemedicine resources, including a hub that helps clinics get started, preps patients for their appointments, and other services.

Courtesy of Tidepool as well, check out this beneficial webinar with Dr. Mark Heyman about the most urgent mental health concerns to manage while navigating COVID-19 and diabetes.

We want to thank all of our partners who contributed effort, and we look forward to sharing more resources as they become available!